I know Alan Kohler and he's a good bloke but if his analysis on csg this weekend is anything like the five minute segment he did last week on ShellPetroChina's bid for Arrow it won't reveal much we don't already know.
Last week's segment was just fluff, wallpaper, spac filler, less than useless. Just an analyst, no hard qestions or analysis of what might happen.
I hope I'm wrong, but I think this week's segment may be more of the same.
- Forums
- ASX - By Stock
- ESG
- bid over $2.00?
bid over $2.00?, page-13
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ESG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online